Schedule 13G ownership disclosure
Zosano Pharma Corp
Security class unavailable · CUSIP: 98979H103
Event date: 2017-03-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,269,846
- Percent of class
- 13.5100%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-17-019647
- Form type
- SC 13G
- Filer
- Amzak Capital Management, LLC
- CIK
- CIK 1565981
- Filed
- Mar 28, 2017
- Reporting period
- Mar 22, 2017
- Description
- Schedule 13G beneficial ownership